Terms: = Ovarian cancer AND FLI1, SIC-1, 2313, ENSG00000151702, Q01543, EWSR2 AND Prognosis
2 results:
1. Clinicopathological significance and underlying molecular mechanism of downregulation of basonuclin 1 expression in ovarian carcinoma.
Liang ZQ; Zhong LY; Li J; Shen JH; Tu XY; Zhong ZH; Zeng JJ; Chen JH; Wei ZX; Dang YW; Huang SN; Chen G
Exp Biol Med (Maywood); 2022 Jan; 247(2):106-119. PubMed ID: 34644201
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in ovarian cancer.
Chatterjee J; Dai W; Aziz NHA; Teo PY; Wahba J; Phelps DL; Maine CJ; Whilding LM; Dina R; Trevisan G; Flower KJ; George AJT; Ghaem-Maghami S
Clin Cancer Res; 2017 Jul; 23(13):3453-3460. PubMed ID: 27986748
[No Abstract] [Full Text] [Related]